Given the implication of enhanced activity of the mTORC1 pathway with ASD, and the high prevalence of ASD in TSC patients [114], several groups have generated iPSC-derived neurons carrying TSC1/2 mutations to investigate the effects of altered TSC-mTORC1 pathway on neuronal development and synaptic physiology. The gene discussed is TSC1; the disease is tuberous sclerosis.